Concurring Statement of Commissioner Alvaro M. Bedoya in the Matter of ExxonMobil Co./Pioneer Natural Resource Co.
Date
By
Alvaro Bedoya, Former Commissioner
Matter Number
241 0004
Displaying 1621 - 1640 of 38405
2 de mayo de 2024
Joint Dissenting Statement of Commissioners Melissa Holyoak and Andrew N. Ferguson in the Matter of Exxon Mobil Corporation
Date
By
Melissa Holyoak, Former Commissioner;
Andrew N. Ferguson, Chairman
Matter Number
241 0004
Para su Difusión
FTC to Host Compliance Webinar on Rule Banning Noncompetes
Fecha
The Federal Trade Commission will host an online compliance webinar on May 14, 2024, at 11a.m. ET to provide an overview of the FTC’s final rule banning noncompetes, which will include information on...
Para su Difusión
FTC Order Bans Former Pioneer CEO from Exxon Board Seat in Exxon-Pioneer Deal
Fecha
The Federal Trade Commission took action to resolve antitrust concerns surrounding Exxon Mobil Corporation’s (Exxon) $64.5 billion acquisition of oil producer Pioneer Natural Resources by approving a...
1 de mayo de 2024
Para su Difusión
FTC Takes Action Against BlueSnap and its Former CEO and Senior VP for Credit Card Laundering, Processing Payments for Known Scammer
Fecha
The Federal Trade Commission is taking action against payment processing company BlueSnap, Inc., along with its former CEO Ralph Dangelmaier and senior vice president Terry Monteith, charging them...
Para su Difusión
Una acción de la FTC permite obtener $43.6 millones de dólares de parte de la compañía de financiación de sistemas de tratamiento de agua Aqua Finance
Fecha
Una acción de la Comisión Federal de Comercio (FTC, por su sigla en inglés) contra una compañía de financiación de sistemas de tratamiento de agua llamada Aqua Finance, Inc. (AFI) ha dado lugar a un...
Para su Difusión
FTC Action Leads to $43.6 Million in Financial Relief from Water Treatment Financing Company Aqua Finance
Fecha
A Federal Trade Commission action against household water treatment funding company Aqua Finance, Inc. (AFI) has led to a settlement that will provide $20 million in refunds and an additional $23.6...
Para su Difusión
FTC Finalizes Order with InMarket Prohibiting It from Selling or Sharing Precise Location Data
Fecha
The Federal Trade Commission finalized a settlement with digital marketing and data aggregator InMarket Media over allegations the company unlawfully collected and used consumers’ location data for...
Para su Difusión
FTC, DOJ, and HHS Extend Comment Period on Cross-Government Inquiry on Impact of Corporate Greed in Health Care
Fecha
The Federal Trade Commission, the Department of Justice’s (DOJ) Antitrust Division, and the U.S. Department of Health and Human Services (HHS) are extending the deadline by 30 days for the public to...
Case Timeline Item
Kroger Company/Albertsons Companies, Inc., In the Matter of (timeline item) - May 1, 2024
Date
Case Timeline Item
InMarket Media, LLC (timeline item) - May 1, 2024
Date
File
Complaint
(313.55 KB)
File
Decision and Order
(306.56 KB)
File
Attachment A: Respondent’s Email Notice
(248.49 KB)
Case Timeline Item
W. Bret Calhoun, In the Matter of (timeline item) - May 1, 2024
Date
File
Application for Stay
(183.87 MB)
File
Application for Review
(1.74 MB)
Case Timeline Item
Exxon Mobil Corporation, In the Matter of (timeline item) - May 1, 2024
Date
File
Agreement Containing Consent Order
(2.34 MB)
File
Complaint (Redacted Public Version)
(226.47 KB)
File
Decision and Order (Redacted Public Version)
(145.41 KB)
File
Analysis to Aid Public Comment
(169.48 KB)
30 de Abr de 2024
Para su Difusión
FTC and FCC Sign Memorandum of Understanding on Continued Cooperation on Consumer Protection Issues
Fecha
The Federal Trade Commission and the Federal Communications Commission (FCC) have signed a Memorandum of Understanding (MOU) reiterating the agencies’ ongoing cooperation on consumer protection...
Para su Difusión
FTC Expands Patent Listing Challenges, Targeting More Than 300 Junk Listings for Diabetes, Weight Loss, Asthma and COPD Drugs
Fecha
Today, the Federal Trade Commission expanded its campaign against pharmaceutical manufacturers’ improper or inaccurate listing of patents in the Food and Drug Administration’s (FDA) Orange Book...
Displaying 1621 - 1640 of 38405